Novasep’s HY restructuring approved by court
Novasep, the French supplier of ingredients to the biotech industry, has achieved all necessary conditions for its proposal to restructure its high yield bonds. The news follows Italian directories group Seat Pagine Gialle’s success last week in obtaining consent for its restructuring.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts